The single intranigral injection of LPS as a new model for studying the selective effects of inflammatory reactions on dopaminergic system

Neurobiology of Disease

Volumn 7, Issue 4, 2000, Pages 429-447

  Herrera, A J ^a   Castano A ^a   Venero, J L ^a   Cano, J ^a   Machado, A ^a  

^a UNIVERSITY OF SEVILLE   (Spain)

Author keywords

Astroglia; Brain; Dopaminergic degeneration; Inflammation; Microglia

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; DOPAMINERGIC SYSTEM; FEMALE; INFLAMMATION; MICROGLIA; NIGRONEOSTRIATAL SYSTEM; NONHUMAN; PARKINSON DISEASE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RAT; SUBSTANTIA NIGRA;

EID: 0033835748     PISSN: 09699961     EISSN: None     Source Type: Journal    
DOI: 10.1006/nbdi.2000.0289     Document Type: Article

References (64)

1. Microglial response to 6-hydroxy-dopamine-induced substantia nigra lesions
2. The kinetics and morphological characteristic of the macrophage-microglial response to kainic acid-induced neuronal degeneration
3. Intracerebral injection of proinflammatory cytokines or leukocyte chemotaxins induces minimal myelomonocytic recruitment to the parenchyma of the central nervous system
4. The acute inflammatory response to lipopolysaccharide in CNS parenchyma differs from that in other body tissues
5. Cytotoxicity of microglia
6. Iron-melanin interaction and lipid peroxidation: Implications for Parkinson's disease
7. Inflammatory cytokines within the central nervous system: Sources, function and mechanism of action
8. Short- and long-term consequences of intracranial injections of the excitotoxin, quinolinic acid, as evidence by GFAP immunohistochemistry of astrocytes
9. Dissapearance of astrocytes and invasion of macrophages following crush injury of adult rodent optic nerves: Implications for regeneration
10. Immnunocytochemical analysis of tumor necrosis factor and its receptor in Parkinson's disease
11. Glia-dependent neurotoxicity and neuroprotection in mesencephalic culture
12. Dopamine neurons in the pars compacta of the substantia nigra contain acetylcholinesterase: Histochemical correlations on the same brain sections
13. Effects of a short period of vitamin-E deficient diet in the turnover of different neurotransmitters in substantia nigra and striatum of the rat
14. Lipopolysaccharide intranigral injection induces inflammatory reaction and damage in nigrostriatal dopaminergic system
15. Tumor necrosis factor-α production by astrocytes: Induction by lipopolysaccharide, IFN-α and IL-1β
16. Activation of endogenous antioxidant defenses in neuronal cells prevents free radical-mediated damage
17. Glial changes following an excitotoxic lesion in the CNS-II. Astrocytes
18. Choline acetyltransferase and acetylcholinesterase containing projections from the basal forebrain to the amygdaloid complex of the rat
19. The neurotrophic effects of fibroblast growth factors on dopaminergic neurons in vitro are mediated by mesencephalic glia
20. Sustained seizures cause circumscribed cerebral changes in glial fibrillary acidic protein, neurofilament and laminin immunofluorescence
21. Two genes encode distinct glutamate decarboxylases
22. Comparative localization of mRNAs encoding two forms of glutamic acid decarboxylase with nonradioactive in situ hybridization methods
23. Differential activation of microglia and astrocytes in aniso- and isomorphic gliotic tissue
24. Increased protein oxidation in human substantia nigra pars compacta in comparison with basal ganglia and prefrontal cortex measured with an improved dinitrophenylhydrazine assay
25. Animal models of Parkinson's disease: An empirical comparison with the phenomenology of the disease in man
26. Altered brain matabolism of iron as a case of neurodegenerative diseases
27. Reactive glia as rivals in regulating neuronal survival
28. Brain glia release factors with opposing actions upon neuronal survival
29. Astroglia in CNS injury
30. Glial cell line-derived neurotrophic factor exerts neurotrophic effects on dopaminergic neurons in vitro and promotes their survival and regrowth after damage by 1-methyl-4-phenylpyridinium
31. Role of cytokines in lipopolysaccharide-induced functional and structural abnormalities of astrocytes
32. FcεRII/CD23 is expressed in Parkinson's disease and induces, in vitro, production of nitric oxide and tumor necrosis factor-α in glial cells
33. Astroglial response in the excitotoxically lesioned neostriatum and its projection areas in the rat
34. Theories on the etiology and pathogenesis of Parkinson's disease
35. Cytokine regulation of embryonic rat dopamine and serotonin neuronal survival in vitro
36. Neuroglial response to the dopaminergic neurotoxicant 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mouse striatum
37. Comparison of dopamine uptake in the basolateral amygdaloid nucleus, caudate-putamen and nucleus accumbens of the rat
38. Microglial and astroglial reactions to ischemic and kainic acid-induced lesions of the adult rat hippocampus
39. Study of the transformation of ameboid microglial cells into microglia labeled with the isolectin Griffonia simplicifolia in postnatal rats
40. Physiological and pathological aspects of astrocytes swelling
41. Microglial and astrocytic involvement in a murine model of Parkinson's disease induced by 1-mehyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)
42. The early reactions of non-neuronal cells to brain injury
43. Heterogeneity in the distribution and morphology of microglia in the normal adult mouse brain
44. Production of tumor necrosis factor and other cytokines by astrocytes stimulated by lipopolysaccharide or a neurotropic virus
45. GDNF: A glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons
46. Rate of cell death in Parkinsonism indicates active neuropathological process
47. Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson's and Alzheimer's disease brains
48. Tumor necrosis factor-alpha (TNF-alpha) increases both in the brain and in the cerebrospinal fluid from parkinsonian patients
49. Lipopolysaccharide intracerebral administration induces minimal inflammatory reaction in rat brain
50. Astrocytes response to CNS injury
51. Quantitative aspects of reactive gliosis: A review
52. Characterization of the origins of astrocytes response to injury using the dopaminergic neurotoxicant, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine
53. Astroglial cell alteration caused by neurotoxins: Immunohistochemical observations with antibodies to glial fibrillary cidic protein, laminin and tyrosine hydroxylase
54. Pathological changes in dendrites of substantia nigra neurons in Parkinson's disease: A Golgi study
55. Inflammation in the nervous system
56. TGF beta 2 and TGF beta 3 are potent survival factors for midbrain dopaminergic neurons
57. 3H]tyrosine by charcoal
58. Thalamic retrograde degeneration following cortical injury: An excitotoxic process?
59. Nigral and striatal comparative study of the neurotoxic action of 1-Methyl-4-phenylpyridinium ion: Involvement of dopamine uptake system
60. Astrocytes responses to dopaminergic denervation by 6-hydroxydopamine and 1-methyl-4-phenyl-1,2,3,4-tetrahydropyridine as evidenced by glial fibrillary acidic protein immunohistochemistry
61. Time course changes in the dopaminergic nigrostriatal system following transection of the medial forebrain bundle: Detection of oxidatively modified proteins in substantia nigra
62. Vimentin immunoreactivity in normal and pathological human brain tissue
63. The role of iron in senescence of dopaminergic neurons in Parkinson's disease